Page 23 - ப்ராடக்ட் சேவை வளர்ச்சி மக்கள் விருதுகள் பிரிவுகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ராடக்ட் சேவை வளர்ச்சி மக்கள் விருதுகள் பிரிவுகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ராடக்ட் சேவை வளர்ச்சி மக்கள் விருதுகள் பிரிவுகள் குழு Today - Breaking & Trending Today

VOYAGER 12-Channel Adjustable Tip Spacing Pipettes from INTEGRA Biosciences

Rating:
Application Area:384 well plate production
After several months of manual plate production using single channel and manual pipettes, we began to look for an adjustable multi-channel solution. After trialing many competitors we gave the INTEGRA Voyager 12 channel adjustable pipette a try and have only been pleased. The adjustable tip width means switching between different plate sizes is simple, dispensing volumes are accurate even if the pipette is jogged or dropped and controls and programming are easy to understand and comprehensive. I have never been so excited about a pipette before! This should be your first choice for all high throughput dispensing needs. ....

Voyager 12 Channel Adjustable Tip Spacing Pipettes , Integra Biosciences , ஒருங்கிணைப்பு உயிர் அறிவியல் ,

Raptor Polar X LC Columns from Restek Corp.

Read independent reviews on Raptor Polar X LC Columns from Restek Corp. on SelectScience ....

Raptor Polarx Lc Columns , Restek Corp ,

Tommy Bahama Maritime Triumph, A New Fragrance For Men

NEW YORK, April 6, 2021 /PRNewswire/ Tommy Bahama, the iconic island lifestyle brand, announces the debut of the limited-edition men s fragrance, Maritime Triumph. The newest addition to its scent ....

Frank Voelkl , Vince Camuto , Pierre Cardin , Kenneth Cole , Paris Hilton , Jason Wu , Perfumania Holdings Inc , Tommy Bahama Group Inc , Oxford Industries Inc , Tommy Bahama , Maritime Triumph , Cedar Leaf , Cashmere Woods , Senior Perfumer , Pimento Berries , Eau De Cologne , Sofia Vergara , Tommy Bahama Group , Oxford Industries , Tommy Bahama Restaurant , Tommy Bahama Marlin , Nyse Oxm , New York , North East , United States Of America , North America ,

Lyra Therapeutics : Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual

New data presented includes:
- First product candidate found to be effective in non-polyp patients in addition to polyp patients in a clinical trial, based on 100% of patients in both groups achieving SNOT-22 MCID at week 24 with LYR-210 (7500µg group) -
- LYR-210 (7500µg) decreased ethmoid opacification at week 24, a measure of disease modification -
- LYR-210 (7500µg) reduced the need for rescue medication -
- Separately, Lyra also reported an analysis showing that LYR-210 (7500µg) achieved statistically significant improvement across 3 cardinal symptoms at week 24 in the LANTERN study -
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today presented data from its Phase 2 LANTERN study of LYR-210, the company’s lead long-acting product candidate fo ....

Robert Kern , Anders Cervin , Maria Palasis , Rodney Williams Memorial Foundation , University Of Queensland , Lyra Therapeutics Inc , Lyra Therapeutics , Combined Otolaryngology Spring Meetings , Professor Anders Cervin , Garnett Passe , Rodney Williams Memorial Foundation Chair , Principal Investigator , Oral Presentation , Non Polyp Patients , Cardinal Symptoms , Chief Medical Officer , Chief Executive Officer , Inc Stock Exchange , Press Release , Both Lyra , ராபர்ட் கர்ன் , ரோட்னி வில்லியம்ஸ் நினைவகம் அடித்தளம் , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து , லைரா சிகிச்சை இன்க் , லைரா சிகிச்சை , கார்னெட் கடந்த காலம் ,

Molecular Partners : Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR

Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR
. | April 11, 2021 ....

United States , Shai Biran , Prodrug Darpin , Seth Lewis , Thomas Schneckenburger , Daniel Steiner , Engager Program , American Association For Cancer Research , Research Of Molecular Partners , Company On Twitter At Molecularprtnrs , Molecular Partners Shares New Preclinical Data , Cell Engager Program , American Association , Cancer Research , Molecular Partners , Scientific Presentations , Molecular Partner , Molecular Partners Ag Stock Exchange , Press Release , At Moln Ch0256379097 , ஒன்றுபட்டது மாநிலங்களில் , ஷாய் பிரன் , சேதி லெவிஸ் , டேனியல் ஸ்டீனர் , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , அமெரிக்கன் சங்கம் ,